Anesthesia, GeneralNCT04238507
A Clinical Study of the USASK Airway - An Improved Oral Airway for Bag-Mask Ventilation
A study testing Guedel airway and USASK airway in people with Anesthesia, General, run by University of Saskatchewan at 1 site in Canada.
Trial summary
A clinical study of USASK AIRWAY - An Improved Oral Airway for Bag-mask Ventilation A clinical study of MA AIRWAY - An Improved Oral Airway for Bag-mask Ventilation We report a study with University Research Ethics Board approval of a new oral airway device, the McKay Airway (MA), designed for easy maintenance of… Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- Anesthesia, General
- What is being tested?
- Guedel airway and USASK airway
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 65 participants
- Where
- 1 siteCanada
- Study dates
- 22 Jul 2019to Sep 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Inclusion Criteria: Participants are of three kinds: learners, patients, and anesthesiologists. Learners will be consenting medical students, residents from specialties other than anesthesiology, or naïve learners in the Respiratory Technician or Emergency Medical Technician courses, all of whom are routinely rotated through the Saskatoon operating rooms (ORs) to learn airway management. Excepted will be learners who do not wish to participate. Patients will be consenting adult (age ≥ 18 years) patients booked into the operating rooms of SHR for elective surgery under general anesthesia (GA). BMV is normal clinical practice for all patients as part of the induction and emergence phases of GA -
Exclusion Criteria: Excepted patients will be those with temporomandibular joint disorders, those who do not wish to participate, those whom the attending anesthesiologist feels puts them at any added risk by participating, and those whose anesthetic plan is changed from GA to a regional anesthetic technique
-
Trial locations and contacts
1 site in 1 country.
Canada1 site, 1 recruiting
- Recruiting
Saskatoon Health Region, 410 22nd Street East
Saskatoon, Saskatchewan, S7K 5T6
Joanne Franko, (306) 655-3350, joanne.franko@saskatoonhealthregion.ca
William PS McKay, MD
About this study
A clinical study of USASK AIRWAY - An Improved Oral Airway for Bag-mask Ventilation
A clinical study of MA AIRWAY - An Improved Oral Airway for Bag-mask Ventilation We report a study with University Research Ethics Board approval of a new oral airway device, the McKay Airway (MA), designed for easy maintenance of jaw-thrust (see illustration) for first responders who may perform bag-mask venti-lation (BMV) infrequently, and who often do not perform it well. Null hypothesis: naïve learners' time to achieve exhaled tidal volume (VE) >300ml will be no dif-ferent using MA than using a Guedel oropharyngeal airway (OPA) on anesthetized patients. Design was a repeated-measures unblinded controlled trial with blinded randomization of the order of airway use, comparing MA versus OPA conducted from July until December 2019. Anesthesiologists' decision to intervene and comments were recorded. Consenting learners included medical students, resi-dents from specialties other than anesthesiology, operating room staff, or naïve learners in technical courses scheduled in the operating rooms to be taught airway management. Patients were consenting adults booked for elective surgery under general anesthesia (GA). Excepted patients were those with loose incisors, tem-poromandibular joint disorders, reflux, those who did not wish to participate, and those whom the attending anesthesiologist felt put them at any added risk by par-ticipating. For patients with missing teeth, we padded the MA surface with 1cm thick stick-on sponge (Reston™ Self-Adhering Foam Pads; 3M, Maplewood MN USA). Patients were under the direct care of the consenting staff anesthesiologist for that OR. They were recruited in Pre-Admission Clinic, the hospital wards, Same-Day and Day-Surgery units, and in the OR holding area.
The experimental procedure included normal preoxygenation, induction of anesthesia, and BMV by the attending anesthesiologist as needed to assure high oxygen saturation prior to opening an opaque numbered envelope to randomly choose which airway to use first. We mimicked a self-inflating BMV device with the anesthetic machine by setting the Adjustable Pressure Limiting (APL) valve to >30cm water pressure and using the oxygen flush to ensure that the reservoir bag was filled between breath attempts. With the randomized airway in place, learners applied the mask with their left hand, squeezing the bag with their right approxi-mately every 3s. We timed from the first bag squeeze until VE exceeded 300ml, then repeated the experiment with the other airway. We approached 56 patients, recruited 34 female and 20 male, and obtained data for 51. One obese patient had severe succinylcholine fasciculations with rapid profound desaturation and the an-esthesiologist took over immediately, and for two the anesthesiologist misunder-stood the experiment. Time measurements were analysed with Wilcoxon's Signed Rank test, incidences with Fisher's Exact test or Chi Square. MA allowed faster adequate ventilation than OPA: Hodges-Lehmann median difference: 6s [95% CI 5 to 6.3s]; quartiles: OPA 9.5 to 37s; MA 7 to 16s range: OPA 5 to 78s; MA 2 to 49s; p = 0.02. When used first, the MA was faster than the OPA 30% of times compared to 11% when OPA was used first (p = 0.04), suggesting that MA may be easier to learn. Comments: 16 preferred the MA, 2 the OPA, and 15 had no preference (p = 0.02 compared to equal preferences). Further studies are warrant-ed.
Read the detailed description
INTRODUCTION A newly invented airway device, the McKay Airway (MA) may improve ventilating a patient with a mask and self-inflating bag attached to an oxygen source (bag-mask ventilation: BMV), a common and often lifesaving step in anesthesia, intensive care, and emergency practice. BMV has been shown to frequently provide no or inadequate ventilation in the hands of beginners or those who practice it rarely; studies report successful BMV by beginners of 43 to 85%, with the latter requiring an average time of 44s to achieve successful ventilation. A study is proposed to assess the functionality of the device for BMV comparing MA with the widely used Guedel oropharyngeal airway (OPA). The MA does not cause gagging or vomiting in patients with a fluctuating level of consciousness.
Null hypothesis: Naïve learners will perform BMV no better using the new MA device than using a Guedel airway (current standard device in use for BMV) as measured by time to Vt > 300ml.
Design: Repeated-measures unblinded randomized controlled trial (RCT), with randomization of the order of use, comparing BMV using a Guedel air or the MA device on the same participant.
Primary outcome: Time from applying the mask to achieving ventilation with Vt > 300ml.
Secondary outcomes: An anesthesiologist's decision to intervene will be noted and counted should it occur. If there is adequate ventilation by 30s, the attempt will be considered a success; otherwise a failure. Scores will be recorded on rating scales for each BMV method: ease of insertion, ease of holding the mask properly, ease of obtaining a good seal, ease of obtaining an open airway, and likelihood of employing the method in practice. Comments about overall impression will be recorded.
Participants: Participants are of three kinds: learners, patients, and anesthesiologists. Learners will be consenting medical students, residents from specialties other than anesthesiology, or naïve learners in the Respiratory Technician or Emergency Medical Technician courses, all of whom are routinely rotated through the Saskatoon operating rooms (ORs) to learn airway management. Excepted will be learners who do not wish to participate. Patients will be consenting adult (age ≥ 18 years) patients booked into the operating rooms of SHR for elective surgery under general anesthesia (GA). BMV is normal clinical practice for all patients as part of the induction and emergence phases of GA. Excepted patients will be those with temporomandibular joint disorders, those who do not wish to participate, those whom the attending anesthesiologist feels puts them at any added risk by participating, and those whose anesthetic plan is changed from GA to a regional anesthetic technique. They will be under the direct constant care of the consenting staff anesthesiologist for that OR. Excepted anesthesiologists will be those who do not wish to participate in the study in general or for any particular patient or operation.
Number of participants: Sample size calculation for repeated measures t-test with effect size 0.33, alpha 0.05, power 0.8 is 59. We will recruit 65 to 80 for logistical OR exigencies.
Consent: With University of Saskatchewan Research Ethics Board approval, investigators, will recruit learners, anesthesiologists, and patients. Patients will be recruited in Pre-Admission Clinic (PAC), on the hospital wards, in Same-Day and Day-Surgery units, and in the OR holding area.
Data and privacy concerns will accord with University of Saskatchewan Ethics Committee principles.
Patient safety: The experiment will be overseen by the attending specialist anesthesiologist who will intervene immediately as needed and proceed as clinically indicated if even the smallest issue of patient safety arises during learners' attempts at BMV. This is not different from the normal clinical teaching situation. Risk to participating patients is minimal.
Interventions: Prior to their rotation in the ORs, consenting learners will watch teaching videos to learn BMV using OPA and MA.
Statistical analysis. Demographic data will be tabulated as observational. Time measurements will be tested for normality by Shapiro-Wilk, and if passed, by paired t-test; otherwise by Wilcoxon Signed Rank Test. Incidence data will be compared by Fishers Exact test or Chi-squared.
- Conditions
- Anesthesia, General
- Being tested
- Guedel airway, USASK airway
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Guedel airwayDevice
Following induction of GA, air:O2 flows will be set at 0:10L, the Adjustable Pressure Limiting (APL) valve set to 50cm water pressure, and the reservoir bag filled. The learner will perform BMV with a Guedel airway placed by the anesthesiologist, while the anesthesiologist ensures that the reservoir bag is filled between breath attempts by using the oxygen flush.
USASK airwayDevice
Following induction of GA, air:O2 flows will be set at 0:10L, the Adjustable Pressure Limiting (APL) valve set to 50cm water pressure, and the reservoir bag filled. The learner will perform BMV with a USASK airway placed by the anesthesiologist, while the anesthesiologist ensures that the reservoir bag is filled between breath attempts by using the oxygen flush.
| Study group | Role | What they receive |
|---|---|---|
| Guedel airway (OPA) | Active comparator | Following induction of GA, air:O2 flows will be set at 0:10L, the Adjustable Pressure Limiting (APL) valve set to 50cm water pressure, and the reservoir bag filled. The learner will perform BMV with a Guedel airway placed by the anesthesiologist, while the anesthesiologist ensures that the reservoir bag is filled between breath attempts by using the oxygen flush. Receives: Device: Guedel airway |
| McKay Airway (MA) | Active comparator | Following induction of GA, air:O2 flows will be set at 0:10L, the Adjustable Pressure Limiting (APL) valve set to 50cm water pressure, and the reservoir bag filled. The learner will perform BMV with a USASK airway placed by the anesthesiologist, while the anesthesiologist ensures that the reservoir bag is filled between breath attempts by using the oxygen flush. Receives: Device: USASK airway |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time from applying the mask to achieving ventilation
Time from applying the mask to achieving ventilation with tidal volume >300ml.
Measured: 1 minute
Secondary outcomes (1)
airway use questions
An anesthesiologist's decision to intervene and take over BMV will be noted and counted should it occur. If there is adequate ventilation by 30s, the attempt will be considered a success; otherwise a failure. Scores will be recorded on rating scales for each BMV method: ease of insertion, ease of holding the mask properly, ease of obtaining a good seal, ease of obtaining an open airway, and likelihood of employing the method in practice. Comments about overall impression will be recorded.
Measured: 15 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jan 2020
- Study start22 Jul 2019
- Primary completionJul 2020 (estimated)
- Study completionSep 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Anesthesia, GeneralStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Device feasibility
- Allocation
- Randomised
- Intervention model
- Single group
- Model description
- : The proposed experiment is a repeated-measures unblinded randomized controlled trial (RCT), with randomization of the order of use, comparing BMV using a Guedel air or the UA device on the same participant.
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 65 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Saskatchewan
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, William McKay, University of Saskatchewan
- Investigators
- Jonathan Gamble, Study director, University of Saskatchewan Dept. of Anesthesia Research Director
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04238507
- Sponsor's protocol ID
- BIO-1324
- Status last verified
- Jan 2020
- First submitted
- 12 Aug 2019
- Last updated
- 23 Jan 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Jan 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinical Study of the USASK Airway - An Improved Oral Airway for Bag-Mask Ventilation
- ClinicalTrials.gov ID
- NCT04238507
- Acronym / sponsor ID
- BIO-1324
- Conditions
- Anesthesia, General
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 65 participants (estimated)
- Lead sponsor
- University of SaskatchewanUniversity, hospital or other
- Study start
- 22 Jul 2019 (actual)
- Primary completion
- Jul 2020 (estimated)
- Study completion
- Sep 2020 (estimated)
- First posted
- 23 Jan 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A clinical study of USASK AIRWAY - An Improved Oral Airway for Bag-mask Ventilation
A clinical study of MA AIRWAY - An Improved Oral Airway for Bag-mask Ventilation We report a study with University Research Ethics Board approval of a new oral airway device, the McKay Airway (MA), designed for easy maintenance of jaw-thrust (see illustration) for first responders who may perform bag-mask venti-lation (BMV) infrequently, and who often do not perform it well. Null hypothesis: naïve learners' time to achieve exhaled tidal volume (VE) >300ml will be no dif-ferent using MA than using a Guedel oropharyngeal airway (OPA) on anesthetized patients. Design was a repeated-measures unblinded controlled trial with blinded randomization of the order of airway use, comparing MA versus OPA conducted from July until December 2019. Anesthesiologists' decision to intervene and comments were recorded. Consenting learners included medical students, resi-dents from specialties other than anesthesiology, operating room staff, or naïve learners in technical courses scheduled in the operating rooms to be taught airway management. Patients were consenting adults booked for elective surgery under general anesthesia (GA). Excepted patients were those with loose incisors, tem-poromandibular joint disorders, reflux, those who did not wish to participate, and those whom the attending anesthesiologist felt put them at any added risk by par-ticipating. For patients with missing teeth, we padded the MA surface with 1cm thick stick-on sponge (Reston™ Self-Adhering Foam Pads; 3M, Maplewood MN USA). Patients were under the direct care of the consenting staff anesthesiologist for that OR. They were recruited in Pre-Admission Clinic, the hospital wards, Same-Day and Day-Surgery units, and in the OR holding area.
The experimental procedure included normal preoxygenation, induction of anesthesia, and BMV by the attending anesthesiologist as needed to assure high oxygen saturation prior to opening an opaque numbered envelope to randomly choose which airway to use first. We mimicked a self-inflating BMV device with the anesthetic machine by setting the Adjustable Pressure Limiting (APL) valve to >30cm water pressure and using the oxygen flush to ensure that the reservoir bag was filled between breath attempts. With the randomized airway in place, learners applied the mask with their left hand, squeezing the bag with their right approxi-mately every 3s. We timed from the first bag squeeze until VE exceeded 300ml, then repeated the experiment with the other airway. We approached 56 patients, recruited 34 female and 20 male, and obtained data for 51. One obese patient had severe succinylcholine fasciculations with rapid profound desaturation and the an-esthesiologist took over immediately, and for two the anesthesiologist misunder-stood the experiment. Time measurements were analysed with Wilcoxon's Signed Rank test, incidences with Fisher's Exact test or Chi Square. MA allowed faster adequate ventilation than OPA: Hodges-Lehmann median difference: 6s [95% CI 5 to 6.3s]; quartiles: OPA 9.5 to 37s; MA 7 to 16s range: OPA 5 to 78s; MA 2 to 49s; p = 0.02. When used first, the MA was faster than the OPA 30% of times compared to 11% when OPA was used first (p = 0.04), suggesting that MA may be easier to learn. Comments: 16 preferred the MA, 2 the OPA, and 15 had no preference (p = 0.02 compared to equal preferences). Further studies are warrant-ed.
Detailed description
INTRODUCTION A newly invented airway device, the McKay Airway (MA) may improve ventilating a patient with a mask and self-inflating bag attached to an oxygen source (bag-mask ventilation: BMV), a common and often lifesaving step in anesthesia, intensive care, and emergency practice. BMV has been shown to frequently provide no or inadequate ventilation in the hands of beginners or those who practice it rarely; studies report successful BMV by beginners of 43 to 85%, with the latter requiring an average time of 44s to achieve successful ventilation. A study is proposed to assess the functionality of the device for BMV comparing MA with the widely used Guedel oropharyngeal airway (OPA). The MA does not cause gagging or vomiting in patients with a fluctuating level of consciousness.
Null hypothesis: Naïve learners will perform BMV no better using the new MA device than using a Guedel airway (current standard device in use for BMV) as measured by time to Vt > 300ml.
Design: Repeated-measures unblinded randomized controlled trial (RCT), with randomization of the order of use, comparing BMV using a Guedel air or the MA device on the same participant.
Primary outcome: Time from applying the mask to achieving ventilation with Vt > 300ml.
Secondary outcomes: An anesthesiologist's decision to intervene will be noted and counted should it occur. If there is adequate ventilation by 30s, the attempt will be considered a success; otherwise a failure. Scores will be recorded on rating scales for each BMV method: ease of insertion, ease of holding the mask properly, ease of obtaining a good seal, ease of obtaining an open airway, and likelihood of employing the method in practice. Comments about overall impression will be recorded.
Participants: Participants are of three kinds: learners, patients, and anesthesiologists. Learners will be consenting medical students, residents from specialties other than anesthesiology, or naïve learners in the Respiratory Technician or Emergency Medical Technician courses, all of whom are routinely rotated through the Saskatoon operating rooms (ORs) to learn airway management. Excepted will be learners who do not wish to participate. Patients will be consenting adult (age ≥ 18 years) patients booked into the operating rooms of SHR for elective surgery under general anesthesia (GA). BMV is normal clinical practice for all patients as part of the induction and emergence phases of GA. Excepted patients will be those with temporomandibular joint disorders, those who do not wish to participate, those whom the attending anesthesiologist feels puts them at any added risk by participating, and those whose anesthetic plan is changed from GA to a regional anesthetic technique. They will be under the direct constant care of the consenting staff anesthesiologist for that OR. Excepted anesthesiologists will be those who do not wish to participate in the study in general or for any particular patient or operation.
Number of participants: Sample size calculation for repeated measures t-test with effect size 0.33, alpha 0.05, power 0.8 is 59. We will recruit 65 to 80 for logistical OR exigencies.
Consent: With University of Saskatchewan Research Ethics Board approval, investigators, will recruit learners, anesthesiologists, and patients. Patients will be recruited in Pre-Admission Clinic (PAC), on the hospital wards, in Same-Day and Day-Surgery units, and in the OR holding area.
Data and privacy concerns will accord with University of Saskatchewan Ethics Committee principles.
Patient safety: The experiment will be overseen by the attending specialist anesthesiologist who will intervene immediately as needed and proceed as clinically indicated if even the smallest issue of patient safety arises during learners' attempts at BMV. This is not different from the normal clinical teaching situation. Risk to participating patients is minimal.
Interventions: Prior to their rotation in the ORs, consenting learners will watch teaching videos to learn BMV using OPA and MA.
Statistical analysis. Demographic data will be tabulated as observational. Time measurements will be tested for normality by Shapiro-Wilk, and if passed, by paired t-test; otherwise by Wilcoxon Signed Rank Test. Incidence data will be compared by Fishers Exact test or Chi-squared.
Study design
- Primary purpose
- Device feasibility
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
- Model description
- : The proposed experiment is a repeated-measures unblinded randomized controlled trial (RCT), with randomization of the order of use, comparing BMV using a Guedel air or the UA device on the same participant.
| Arm | Type | Receives |
|---|---|---|
| Guedel airway (OPA) | Active comparator | Device: Guedel airwayFollowing induction of GA, air:O2 flows will be set at 0:10L, the Adjustable Pressure Limiting (APL) valve set to 50cm water pressure, and the reservoir bag filled. The learner will perform BMV with a Guedel airway placed by the anesthesiologist, while the anesthesiologist ensures that the reservoir bag is filled between breath attempts by using the oxygen flush. |
| McKay Airway (MA) | Active comparator | Device: USASK airwayFollowing induction of GA, air:O2 flows will be set at 0:10L, the Adjustable Pressure Limiting (APL) valve set to 50cm water pressure, and the reservoir bag filled. The learner will perform BMV with a USASK airway placed by the anesthesiologist, while the anesthesiologist ensures that the reservoir bag is filled between breath attempts by using the oxygen flush. |
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Guedel airwayFollowing induction of GA, air:O2 flows will be set at 0:10L, the Adjustable Pressure Limiting (APL) valve set to 50cm water pressure, and the reservoir bag filled. The learner will perform BMV with a Guedel airway placed by the anesthesiologist, while the anesthesiologist ensures that the reservoir bag is filled between breath attempts by using the oxygen flush. | Device | Guedel airway (OPA) |
| USASK airwayFollowing induction of GA, air:O2 flows will be set at 0:10L, the Adjustable Pressure Limiting (APL) valve set to 50cm water pressure, and the reservoir bag filled. The learner will perform BMV with a USASK airway placed by the anesthesiologist, while the anesthesiologist ensures that the reservoir bag is filled between breath attempts by using the oxygen flush. | Device | McKay Airway (MA) |
Primary outcome
Time from applying the mask to achieving ventilation
Time frame: 1 minute
Time from applying the mask to achieving ventilation with tidal volume >300ml.
1 secondary outcome
airway use questions
Time frame: 15 minutes
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jan 2020.
- Individual participant dataSharing planned: No
Related trials for Anesthesia, General
Not yet recruitingObservational study
"Comparison of Oxygen Reserve Index (ORI), End-Tidal Oxygen, and Time-Based Preoxygenation Targets With Arterial Blood Gas During Preoxygenation
Preoxygenation Adequacy Assessed by Oxygen Reserve Index, End-tidal Oxygen and Arterial Blood Gas
Not yet recruiting
A Randomized Controlled SaCo-VLM Trial
General Anaesthesia Using Supraglotic Airway
RecruitingPhase 4
Comparison of Hemodynamics and Respiratory Function Between Ciprofol and Propofol in Elderly Patients Undergoing Non-intubated General Anesthesia
Comparison of Hemodynamics and Respiratory Function Between Ciprofol and Propofol in Elderly Patients Undergoing Non-intubated General Anesthesia
Not yet recruiting
Tizanidine Premedication Versus Placebo for Laryngeal Mask Airway Insertion and Recovery in Adults Undergoing Ambulatory Surgery
Airway Management
Not yet recruitingPhase 4
Effect of Prophylactic Dexamethasone vs Placebo on Airway Dimensions Assessed by Ultrasonography in Patients Undergoing Laparoscopic Cholecystectomy
Airway Edema, Postoperative Complications
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jonathan Gamble study director
University of Saskatchewan Dept. of Anesthesia Research Director
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Guedel airway and USASK airway in people with Anesthesia, General, run by University of Saskatchewan at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 23 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact William P McKay, MD (306 250 5344, bill.mckay@usask.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time from applying the mask to achieving ventilation (time frame: 1 minute). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2020; AzTrials last refreshed its copy on 7 Nov 2026.